These success, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 assist the thought of focusing on ACKR3 as a singular approach to modulate the opioid method, which could open new therapeutic avenues for opioid-linked disorders. Exploration on conolidine is restricted, https://stephenk515fwm1.wikinarration.com/user